Session date: 
10/28/2019 - 7:30am to 8:15am

Presenter:  Morteza Naghavi, M.D.    

Learning Objectives:

  • Describe state of the art in ASCVD risk assessment for asymptomatic individuals and the long-waited ACC/AHA adoption of calcium score.
  • Discuss the potential of machine learning in ASCVD risk assessment for asymptomatic individuals.
  • Outline future directions for early detection and treatment of the vulnerable patient; very high-risk asymptomatic individuals at risk of ASCVD events within 12 months.

 

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here. 

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010image within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this series will appear on your Transcript.

Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota